POST Online Media Lite Edition


GenMark appoints chairman

Staff writer |
Carlsbad, Ca., USA - August 12, 2014, Carlsbad, Ca., USA - GenMark Diagnostics, Inc., a molecular diagnostics company, appoints James Fox as chairman of the board.

Article continues below

Dr. Fox has served on the Company's Board since September 2010. Dr. Fox led the start-up of Invetech, an Australian contract research and development company that specializes in healthcare products and complex instruments for international markets. He transformed Invetech into the ASX listed Vision Systems Ltd Group with its principal activity in In-Vitro diagnostics through its Vision BioSystems Ltd subsidiary. Vision Systems was ultimately acquired by Danaher Corporation in 2006.

Dr. Fox left the Vision Systems Group at the completion of its acquisition by Danaher in December 2006 and took up a number of board roles around the world. He currently serves as Chairman of the Board of Biota Pharmaceuticals, Inc., as a director of Air New Zealand Ltd. (he retires from the Air New Zealand board in August this year), and as a director of TTP Group plc (UK).


What to read next

GenMark Diagnostics adds James Fox to the board
GenMark appoints Stephen T. Worland to the board
Hill & Smith Holdings appoints Mark Reckitt as director